Myriad Genetics, Inc. - MYGN - stock price prediction, stock price target, analyst ratings from 17 analysts
Myriad Genetics, Inc. has a share price target of US$ 18, revenue growth forecast of 1.4%, and profit growth estimate of 32.7% for FY25, based on top 17 analyst calls.